[Federal Register Volume 79, Number 195 (Wednesday, October 8, 2014)]
[Notices]
[Pages 60864-60865]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-24032]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Alkermes 
Gainesville LLC

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Alkermes Gainesville LLC applied to be registered as an 
importer of a basic class of controlled substance. The DEA grants 
Alkermes Gainesville LLC registration as an importer of this controlled 
substance.

SUPPLEMENTARY INFORMATION: By notice dated June 10, 2014, and published 
in the Federal Register on June 17, 2014, 79 FR 34551, Alkermes 
Gainesville LLC, 1300 Gould Drive, Gainesville, Georgia 30504, applied 
to be registered as an importer of a certain basic class of controlled 
substance. No comments or objections were submitted for this notice.
    The Drug Enforcement Administration (DEA) has considered

[[Page 60865]]

the factors in 21 U.S.C. 823,952(a) and 958(a) and determined that the 
registration of Alkermes Gainesville LLC to import the basic class of 
controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of Noroxymorphone (9668), a basic class of 
controlled substance listed in schedule II.
    The company plans to import the above listed controlled substance 
for analytical research and testing.
    The import of the above listed basic class of controlled substance 
would be granted only for analytical testing and clinical testing. This 
authorization does not extend to the import of a finished FDA approved 
or non-approved dosage form for commercial distribution in the United 
States.

    Dated: October 1, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-24032 Filed 10-7-14; 8:45 am]
BILLING CODE 4410-09-P